Integral Health Asset Management, LLC Insulet Corp Transaction History

Integral Health Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$161.02 - $206.98 $4.03 Million - $5.17 Million	25,000 New	25,000 $5.05 Million
Q3 2022 Nov 14, 2022	BUY	$224.6 - $281.45 $5.62 Million - $7.04 Million	25,000 New	25,000 $5.74 Million
Q2 2021 Aug 13, 2021	SELL	$225.52 - $304.06 $2.26 Million - $3.04 Million	-10,000 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$235.95 - $293.05 $2.36 Million - $2.93 Million	10,000 New	10,000 $2.61 Million
Q4 2020 Feb 16, 2021	SELL	$215.97 - $265.89 $4.75 Million - $5.85 Million	-22,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$192.55 - $236.59 $770,200 - $946,360	4,000 Added 22.22%	22,000 $5.21 Million
Q2 2020 Aug 14, 2020	BUY	$159.17 - $224.73 $2.87 Million - $4.05 Million	18,000 New	18,000 $3.5 Million

687

62.6M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.3B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.